Comparative efficacy, safety, and cost of iron chelation monotherapy vs. combination therapy in pediatric beta-thalassemia major: a single-center retrospective study
Background Iron chelation therapy is used to maintain iron balance in β-thalassemia major patients who undergo repeated blood transfusions. Objective To compare the efficacy, safety, and cost of iron chelation combination regimens [deferiprone (DFP) + deferoxamine (DFO) or DFP + deferasirox (DFX])]...
Saved in:
Main Authors: | Dewi Sharon Simorangkir (Author), Nafrialdi Nafrialdi (Author), Pustika Amalia Wahidiyat (Author), Vivian Soetikno (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Pediatric Society Publishing House,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Side effect of deferiprone as iron chelator in patient with thalassemia
by: Mikhael Yosia, et al.
Published: (2018) -
Comparison of cardiac dysfunction in thalassemia major patients using deferoxamine or deferiprone as an iron-chelating agent
by: Rosalina Josep, et al.
Published: (2012) -
Liver iron overload and hepatic function in children with thalassemia major
by: Pustika Amalia Wahidiyat, et al.
Published: (2018) -
Hemostatic abnormalities in children with thalassemia major and liver iron overload
by: Pustika Amalia Wahidiyat, et al.
Published: (2018) -
Urinary hepcidin levels in children with beta-thalassemia major on chelation therapy
by: Kritika Goel, et al.
Published: (2022)